I know it is almost a cliché, but if B works on mold and mildew, etc., wouldn't some of the BPs just swoop in and by the whole company, or at least what they can, for almost nothing. I think there are very few secrets in BP, they get all the info and all the articles shot to their boxes every morning. They are pros. The silence speaks volumes, sad to say. I know fungal infections are huge, I just worry that B may not be that effective.

Yep.

Well, it looks like the only hope left is for B to kill a bit of mold or mildew. Hmmmm, of course a good FDA1 or even some more articles backed by just a bit of good numbers could do this, but probably not. Probably the end of the road. Still time before April 15 to bite the moldy IRS bullet, I guess.

I can not access the full document without to pay.

Cost $26, right? Or thereabouts. Often a public or university/college library has what I think is called a JSTOR accounts that allows researchers to access any journal article or research summary free of charge. A phone call can let you find out. Ok, why not I just do it myself, and in the past I have done it; guess I am not sure I want to spend the time. This stock has taken more than a bit of my stock buying enthusiasm (at least for IPIX) away. But I am still long, though not so strong. GLTA you stock buying degenerates out there, and all of the others.

Yes, that's them. AF calls than GI projects. But the thing that really frustrates me is that whoever operates the Contacts (when I've called or emailed) doesn't even have IPIX B on their word list. I'd always hoped (bit not necessarily expected) this relationship could flower in unexpected ways. It hasn't, working with Leo has had a quite expected outcome.

The AF website lists all of the area's products or ongoing product research. As noted, there are 5 IBS- related entries, presumably this is where an IPIX product would appear. IPIX is not one of them.

IPIX does not appear in the 5, IBS-related research areas as of this week. I am still unsure why there has been no explanation (that I could find) for the disappearance or simple loss of interest in IPIX. I've sent a number of personal contact questions asking about IPIX and get no returns. Almost sounds like Leo, but they make far too much money to be associated with our man, in any way.

Really hope you're right, Mack.

A tempest in a tea cup.

Great Song, not so great stock, unfortunately. But we can hope.

I don't think hoping is a recipe for disaster. C'mon, Hound, loosen up, how much did IPIX F you out of? Lots I bet.

Merry Christmas, all. We can hope for better times for IPIX in the upcoming year.

"I think because we been here longer than you and seen the shit that Leo has done since 2014…. No gain since then and you say this is a good stock? You are delusional…"

Angus, I'm not sure why you say I call this a good stock. I've been here since 2016 and have seen the Prurisol, the Covid and all the rest tank our hopes. All that is left is Bea Med and that sure does not seem like much. Until a few years ago I bought shares at the penny level thinking AF, then BeaMed might (might) come home for us. Was wrong on that, it looks like. But part of penny stock plays are longshots with big pay outs resting on even longer odds.

Hound, why are you posting? What purpose are you serving? Are you happy lots of us here lost some real money on IPIX. Why don't you go away, you add nothing. I hate to use my remove.....

Just reread your wise post, Lemon. With the slim chance of an Alfa Sigma "surprise" now nearly zero, imo, and Bea Med not the most hopeful of scenarios, it does look like a sad New Year for IPIX Longs. I've usually looked at time as being reflective of our true status. It does not take much, a few post docs, a few slides, test tubes and maybe even white mice can give a good read on what the real chances of a meds' success is. Of course the FDA1-3 is still needed, but decent sized pharmas have really good instincts on the value of what an IPIX type company has. And as the hour grows late, our chances at some monetary success here diminish with each passing day. Hate to be so gloomy, but that does seem appropriate. Hope someone smarter than I am proves me wrong on all counts.

"I’ll grant that it can get complicated but not in at least the prior 3 years"

Guess you're right, time flies.

It gets complicated, yes? I was supportive of Leo's shot with Prurisol, for example. He tried, and lost. What I was not supportive of was his not sharing the data, so we all could see the exact nature of the failure. I really believed that unnecessary secrecy tanked the pps even more than the failed FDDA 3 alone did. But who knows? It just left a bad taste. I could also go on and moan about the over one million annually in salary for him and his friends. But you get the picture, not black or white, but in Leo's
case, well, dark grey, at least.

Hmmmm, good point. Happy thanksgiving to all.

"... from those you gulled into buying IPIX....."

I can't recall gulling folks into buying this POS. But I do retain some minimal amount of hope.

Win some, lose some, then lose some more. Aren't most of us here a bit addicted? But not you of course.

Happy Thanksgiving to all longs.

I have long believed that since no BP nor anyone else wants to buy miniscule IPIX for such a cheap price, that that simply indicates few if any see any real value here. And that could still be true. But this disregards the fact that at these prices Leo simply doesn't want to sell shares. And there are not enough shares on the open market to wrest control away from his groups (cabal?) anyway. He holds them and he still gets his million dollar dilution deal for he and his few friends. Obviously none of us here can be sure either way. Just speculating. This all came to mind a few days ago when I was on the Alfa Sigma site and saw a significant purchase of a goodly sized little pharma, of course IPIX was not involved.

Thanks, back to basics seems to work well!

Thanks, PJ, must have blown by it. I am still at a loss as to why no BP has at least taken a quick look. Or have they?

I couldn't find any references to Kevetrin. Did a search and nada, though my search function is wobbly. Or am I missing how you referenced Kevetrin?

"Don't you think that there's a risk that you might be overstating the importance of a presentation that's scheduled to be 25 minutes long at the most"

Sometimes there is just a board, sometimes just a board with a small booth, both with no presentations. So, 25 minutes seems a lot more significant than either, though who knows the real value unless someone with the creds goes to the meeting and reports on what they observe, as I see it.

PJ, I always appreciate your posts, but why are you posting these?

"To be fair, Intercept's drug is nearly as crappy as brilacidin"

Fair, hardly. Not even anecdotal. An opinion. Wait until AS finishes its testing of Brilacidin, if it does. And if B for OM, ABSSI and the anti-fungals are nowhere by then, you're probably right, at least as far as the Brilacidin part of your statement is concerned.

Really, who'd buy it? If it were real it would have been sucked up but by a BP years ago. It started out
a potentially powerful treatment, but never got passed the FDA 1. Leo must have figured it had no future or he would have gotten some good coin for it. Leo may may have not been the best CEO from the bagholder's perspective, but I don't think he would have missed an opportunity to get rich.

That seems to be the question?

If it's ok to respond to the steam between you and Daubers. I agree with both of you. Does not look so good for the future. But I am surprised that the pps keeps sinking. Alfa Sigma is still a possibility as is BeaMed, though we are far from certain anything will come of either chance. We all know a little bio is risky at best and always subject to manipulation from the Market Makers and god knows who else, tough at this price and lack of volume there does not seem much value in manipulation. GLTA

I define tries as discussed here on the board. It was and it went nowhere.

In the past there have been one or two attempts to try this.
For whatever reasons it never seems to work. Please don't
ask me to reproduce the chains, I have no idea where or
when they were. Last time I looked there were maybe 1000
or so board members. Do they (we) represent at least 15%
of the outstanding value here, probably. But, really, I have
no idea. .

Hmmm, so it costs $44 to get the full report. Has anyone got the confidence to pop for it? My
concern with this is that salt and vinegar, for example, can kill many viruses and bacterium on a
surface. Bleach can kill virtually all on any surface, though in vivo is a different matter. Still, great
dd, may indicate some good news, though still a long, long way from the money, even if B is
among those in the study. GLTA

Sunspotter

Nice dd.

Interesting points you raise. I think that the 510 process, i.e. the swab as a medical device, can secure approval by being substantially the same as another, previously approved product. But the fact that it is applying an as yet unapproved medical product (Brilacidin) probably messes up any "easy" path. Spotts has a good insight into this process. I'd be interested in any other perspectives he might have. I just can't see how a patent on applying an unapproved product is much of a game changer. Still, need a successful FDA cycle, though that might not be hugely expensive for select nasal uses. Just speculating.

I stopped buying under well 400,000 I am F'd also. .

right you are

I thought Frenchie brought some good dd lots of time. Her overly positive attitude was hers, never bothered me.

Agree, sounded kind or understandable and even reasonable to me. You get kicked a few times, you change your perspective, leastways most of us do. But trying to understand her motives had not been a major priority for me.